ATRS Quote, Trading Chart, Antares Pharma Inc.
home / stock / atrs / atrs quote
$4.39 Last:
1.15% Change Percent:
$4.36 Open:
$4.39 Previous Close:
$4.4 High:
$4.34 Low:
501,937 Volume:
06/24/2021 04:41:34 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ATRS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 4.36 | 4.39 | 4.4 | 4.34 | 501,937 |
| 2021-06-23 | 4.37 | 4.34 | 4.38 | 4.28 | 625,484 |
| 2021-06-22 | 4.19 | 4.35 | 4.385 | 4.12 | 982,058 |
| 2021-06-21 | 4.19 | 4.21 | 4.22 | 4.1 | 753,581 |
| 2021-06-18 | 4.13 | 4.13 | 4.26 | 4.07 | 3,263,241 |
| 2021-06-17 | 4.15 | 4.19 | 4.21 | 4.14 | 794,553 |
| 2021-06-16 | 4.11 | 4.19 | 4.2 | 4.07 | 685,319 |
| 2021-06-15 | 4.22 | 4.14 | 4.2299 | 4.11 | 859,222 |
| 2021-06-14 | 4.45 | 4.23 | 4.45 | 4.18 | 1,553,701 |
| 2021-06-11 | 4.44 | 4.45 | 4.46 | 4.38 | 810,759 |
| 2021-06-10 | 4.45 | 4.42 | 4.49 | 4.41 | 698,919 |
| 2021-06-09 | 4.4 | 4.43 | 4.4721 | 4.39 | 1,013,604 |
| 2021-06-08 | 4.42 | 4.39 | 4.45 | 4.321 | 936,891 |
| 2021-06-07 | 4.14 | 4.4 | 4.4 | 4.1101 | 1,749,294 |
| 2021-06-04 | 4.08 | 4.12 | 4.16 | 4.05 | 834,022 |
| 2021-06-03 | 4.09 | 4.06 | 4.09 | 4.005 | 870,738 |
| 2021-06-02 | 4.14 | 4.1 | 4.155 | 4.06 | 1,492,918 |
| 2021-06-01 | 3.99 | 4.12 | 4.16 | 3.96 | 1,512,429 |
| 2021-05-31 | 4.07 | 3.97 | 4.09 | 3.97 | 1,408,342 |
| 2021-05-28 | 4.07 | 3.97 | 4.09 | 3.97 | 1,408,341 |
News, Short Squeeze, Breakout and More Instantly...
-
EWING, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the ...
-
EWING, N.J., June 15, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to present at the Raymond James Human Health Innova...
-
EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior Vice President of Commercial. Mr. Renda succeeds Patrick Shea who resigned to pur...